当前位置:首页 - 行情中心 - 大洋生物(003017) - 财务分析 - 现金流量表

大洋生物

(003017)

  

流通市值:18.93亿  总市值:22.86亿
流通股本:8348.11万   总股本:1.01亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金492,165,493.26204,160,896.47969,065,747.87645,725,620.44
  收到的税费返还15,608,618.163,495,734.5716,561,187.3923,032,674.37
  收到其他与经营活动有关的现金17,633,831.7714,296,158.133,234,755.0725,361,626.93
  经营活动现金流入小计525,407,943.19221,952,789.141,018,861,690.33694,119,921.74
  购买商品、接受劳务支付的现金352,422,784.13156,470,686.75650,647,745.41428,494,582.57
  支付给职工以及为职工支付的现金71,382,645.0140,970,111.82119,091,570.9288,001,937.45
  支付的各项税费26,432,709.5315,133,173.0348,449,772.2438,524,509.16
  支付其他与经营活动有关的现金23,544,019.0712,575,768.7840,566,691.7725,318,669.46
  经营活动现金流出小计473,782,157.74225,149,740.38858,755,780.34580,339,698.64
  经营活动产生的现金流量净额51,625,785.45-3,196,951.24160,105,909.99113,780,223.1
二、投资活动产生的现金流量:
  收回投资收到的现金10,451,558.7910,000,000152,941,989.588,000,000
  取得投资收益收到的现金52,919.4247,207.242,909,003.98807,031.44
  处置固定资产、无形资产和其他长期资产收回的现金净额70,00070,0003,934,150.4-
  收到的其他与投资活动有关的现金---493,098.74
  投资活动现金流入小计10,574,478.2110,117,207.24159,785,143.8889,300,130.18
  购建固定资产、无形资产和其他长期资产支付的现金90,102,208.1442,633,462.7776,384,580.2744,826,614.66
  投资支付的现金80,000,000-112,300,00048,000,000
  投资活动现金流出小计170,102,208.1442,633,462.77188,684,580.2792,826,614.66
  投资活动产生的现金流量净额-159,527,729.93-32,516,255.53-28,899,436.39-3,526,484.48
三、筹资活动产生的现金流量:
  吸收投资收到的现金--3,900,0003,900,000
  其中:子公司吸收少数股东投资收到的现金--3,900,0003,900,000
  取得借款收到的现金427,993,800215,000,000613,065,961.05556,000,000
  收到其他与筹资活动有关的现金--14,955,956.2914,977,959.96
  筹资活动现金流入小计427,993,800215,000,000631,921,917.34574,877,959.96
  偿还债务支付的现金341,862,956.16164,442,333.34615,224,561.86562,532,232.75
  分配股利、利润或偿付利息支付的现金26,261,593.87846,071.5754,655,503.0628,249,319.53
  支付其他与筹资活动有关的现金424,067.73-4,853,589.154,405,438.73
  筹资活动现金流出小计368,548,617.76165,288,404.91674,733,654.07595,186,991.01
  筹资活动产生的现金流量净额59,445,182.2449,711,595.09-42,811,736.73-20,309,031.05
四、汇率变动对现金及现金等价物的影响-1,469,680.09-962,776.98-232,637.5698,390.46
五、现金及现金等价物净增加额-49,926,442.3313,035,611.3488,162,099.3790,643,098.03
  加:期初现金及现金等价物余额435,406,539.53435,406,539.53347,244,440.16347,244,440.16
  期末现金及现金等价物余额385,480,097.2448,442,150.87435,406,539.53437,887,538.19
补充资料:
  净利润56,923,087.19-100,064,311.65-
  资产减值准备1,386,941.78-18,941,020.93-
  固定资产和投资性房地产折旧34,410,026-69,033,818.04-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧34,410,026-69,033,818.04-
  无形资产摊销1,376,195.65-2,680,949.8-
  长期待摊费用摊销144,214.44-277,877.58-
  处置固定资产、无形资产和其他长期资产的损失21,124.68--2,049,686.99-
  固定资产报废损失115,705.41-2,895,607.63-
  公允价值变动损失-84,184.79-1,463,335.26-
  财务费用1,676,213.52-4,523,386.14-
  投资损失234,176.68--2,789,093.86-
  递延所得税6,324,355.97-1,247,427.44-
  其中:递延所得税资产减少8,188,163.96-4,958,461.74-
    递延所得税负债增加-1,863,807.99--3,711,034.3-
  存货的减少-27,920,290.11-9,878,925.86-
  经营性应收项目的减少-51,544,900.22--128,734,389.8-
  经营性应付项目的增加28,158,499.11-68,786,868.48-
  其他--13,050,400.34-
  现金的期末余额385,480,097.2-435,406,539.53-
  减:现金的期初余额435,406,539.53-347,244,440.16-
  现金及现金等价物的净增加额-49,926,442.33-88,162,099.37-
公告日期2026-08-252026-04-282026-04-282025-10-21
审计意见(境内)标准无保留意见
TOP↑